Home RxNorm 1869883 carbinoxamine maleate 6 MG Oral Tablet [Ryvent] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1869883
RxNorm name carbinoxamine maleate 6 MG Oral Tablet [Ryvent]
Display name RYVENT (Oral Pill)
Full name carbinoxamine maleate 6 MG Oral Tablet [Ryvent]
Term type SBD
Status Active
Strength 6 mg
Dose form Tab
Route Oral Pill
Updated 2026-11-06 11:39:07 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 032017
Active start 032017
Multiple ingredient NO
Branded YES Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength carbinoxamine maleate 6 MG / 1 EACH carbinoxamine carbinoxamine maleate
Derived Ingredient Concepts# FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 15370-130-02 15370-130 RyVent carbinoxamine maleate Carwin Pharmaceutical Associates, LLC ANDA207484 15370-130-10 15370-130 RyVent carbinoxamine maleate Carwin Pharmaceutical Associates, LLC ANDA207484
Drugs@FDA Applications# Application, NDC, Name table Application NDC Name Marketing category Labeler ANDA207484 15370-130 RyVent carbinoxamine maleate ANDA Carwin Pharmaceutical Associates, LLC
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.
NDC11, Source, Active table NDC11 Source Active 15370013002 rxnav_ndcs yes 15370013010 rxnav_ndcs yes
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 13ed76c7-49bd-4527-83dc-b4c7d0da9fff RyVent 6 MG Oral Tablet [PSN] · carbinoxamine maleate 6 MG Oral Tablet [Ryvent] [SBD] · Ryvent 6 MG Oral Tablet [SY] 3 4 20240109
Recently Linked DailyMed Labels# Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC R06AA Aminoalkyl ethers ATC1-4 carbinoxamine FDASPL N0000175587 Histamine-1 Receptor Antagonist EPC has_epc carbinoxamine FDASPL N0000000190 Histamine H1 Receptor Antagonists MOA has_moa carbinoxamine MEDRT D011725 Pyridines CHEM has_ingredient carbinoxamine maleate MEDRT D011725 Pyridines CHEM has_ingredient carbinoxamine MEDRT D000799 Angioedema DISEASE may_treat carbinoxamine MEDRT D000799 Angioedema DISEASE may_treat carbinoxamine maleate MEDRT D001942 Breast Feeding DISEASE ci_with carbinoxamine MEDRT D001942 Breast Feeding DISEASE ci_with carbinoxamine maleate MEDRT D003233 Conjunctivitis, Allergic DISEASE may_treat carbinoxamine MEDRT D003233 Conjunctivitis, Allergic DISEASE may_treat carbinoxamine maleate MEDRT D003327 Coronary Disease DISEASE ci_with carbinoxamine maleate MEDRT D003327 Coronary Disease DISEASE ci_with carbinoxamine MEDRT D004342 Drug Hypersensitivity DISEASE ci_with carbinoxamine maleate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with carbinoxamine MEDRT D015812 Glaucoma, Angle-Closure DISEASE ci_with carbinoxamine maleate MEDRT D015812 Glaucoma, Angle-Closure DISEASE ci_with carbinoxamine MEDRT D006973 Hypertension DISEASE ci_with carbinoxamine maleate MEDRT D006973 Hypertension DISEASE ci_with carbinoxamine MEDRT D007231 Infant, Newborn DISEASE ci_with carbinoxamine maleate MEDRT D007231 Infant, Newborn DISEASE ci_with carbinoxamine MEDRT D007234 Infant, Premature DISEASE ci_with carbinoxamine maleate MEDRT D007234 Infant, Premature DISEASE ci_with carbinoxamine MEDRT D007415 Intestinal Obstruction DISEASE ci_with carbinoxamine MEDRT D007415 Intestinal Obstruction DISEASE ci_with carbinoxamine maleate MEDRT D010437 Peptic Ulcer DISEASE ci_with carbinoxamine MEDRT D010437 Peptic Ulcer DISEASE ci_with carbinoxamine maleate MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat carbinoxamine MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat carbinoxamine maleate MEDRT D012223 Rhinitis, Vasomotor DISEASE may_treat carbinoxamine MEDRT D012223 Rhinitis, Vasomotor DISEASE may_treat carbinoxamine maleate MEDRT D013224 Status Asthmaticus DISEASE ci_with carbinoxamine MEDRT D013224 Status Asthmaticus DISEASE ci_with carbinoxamine maleate MEDRT D014517 Ureteral Obstruction DISEASE ci_with carbinoxamine MEDRT D014517 Ureteral Obstruction DISEASE ci_with carbinoxamine maleate MEDRT D014524 Urethral Obstruction DISEASE ci_with carbinoxamine MEDRT D014524 Urethral Obstruction DISEASE ci_with carbinoxamine maleate MEDRT N0000000190 Histamine H1 Receptor Antagonists MOA has_moa carbinoxamine MEDRT N0000000190 Histamine H1 Receptor Antagonists MOA has_moa carbinoxamine maleate MEDRT N0000000184 Monoamine Oxidase Inhibitors MOA ci_moa carbinoxamine MEDRT N0000000184 Monoamine Oxidase Inhibitors MOA ci_moa carbinoxamine maleate MEDRT N0000008657 Decreased Histamine Activity PE has_pe carbinoxamine MEDRT N0000008657 Decreased Histamine Activity PE has_pe carbinoxamine maleate
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 6 MG ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES ANDA ANDA207484 NAMES Prescribable Synonym RyVent 6 MG Oral Tablet SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon